source
- Kura Oncology launches Caspian Therapeutics with $50M funding to develop next-generation diabetes drugKura Oncology has created a new biotech called Caspian Therapeutics and secured $50 million in financing to advance a next-generation diabetes treatment. The spinout will focus on KO-7246, a highl…
- Biopharma looks beyond China to five alternative overseas markets amid rising geopolitical tensionsGeopolitical tensions between the United States and China are prompting biopharma companies to look beyond the Chinese market for growth. China remains the leading destination, with licensing deal…